Cyclosporin is safe and effective in severe atopic dermatitis of childhood: Report of three cases

Minerva Pediatrica

Volumn 56, Issue 2, 2004, Pages 231-237

  Leonardi, S ^a,c   Marchese, G ^a   Rotolo, N ^a   Miraglia Del Giudice, M ^b   La Rosa, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Department of Pediatrics ^*  (Italy)

Author keywords

Child; Cyclosporine; Dermatitis, atopic, drug therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CYCLOSPORIN A; EMOLLIENT AGENT; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; STEROID;

ARTICLE; ATOPIC DERMATITIS; BLOOD PRESSURE; CASE REPORT; CHILD; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EOSINOPHIL; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; KIDNEY FUNCTION; LICHENOID ERUPTION; LIVER FUNCTION; MALE; PAPULE; PRACTICE GUIDELINE; PRURITUS; REMISSION; SIDE EFFECT; SKIN INFECTION; SKIN INFLAMMATION; SKIN MANIFESTATION; T LYMPHOCYTE ACTIVATION;

CHILD, PRESCHOOL; CYCLOSPORINE; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 3042670475     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Clark R. Cell-mediated and IgE-mediated immune responses in atopic dermatitis. Arch Dermatol 1989;125: 413-6.
2. Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want? Clin Exp Dermatol 1993;18:516-22.
3. Wahlgren CF, Scheeynius A, Hagermark O. Antipruritic effect of oral cyclosporine A in atopic dermatitis. Acta Derm Venereal (Stockh) 1990;70:323-32.
4. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY et al. Double-blind controlled crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-40.
5. Sepp N, Fritsch PO. Can Cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol 1993;128:213-6.
6. Geba GP, Ptak W, Askenase PW. Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. Immunology 2001;104: 235-242.
7. Guarneri B, Califano L, Cannavò SP, Vaccaro M. Cyclosporin A treatment of severe atopic dermatitis in a child [letter]. Pediatr Dermatol 1994;11:186.
8. Berth-Jones J, Finlay AY, Zazi I, Tan B, Goodyear H, Lewis-Jones S et al. Cyclosporin in severe childhood atopic dermatitis: a multicentre study. J Am Acad Dermatol 1996;34:1016-21.
9. Ishii E, Yamamoto S, Sakai R, Hamasaky Y, Miyazaki S. Production of interleukin-5 and the suppressive effect of the Cyclosporin A in childhood severe atopic dermatitis. J Pediatr 1996;128:152-5.
10. Zaki I, Emerson R, Allen BR. Treatment of severe atopic dermatitis in childhood with cyclosporin. Br J Dermatol 1996;135;21-4.
11. Wang SS. Permanent remission of severe atopic dermatitis in a Chinese patient after cyclosporin A therapy [letter]. Acta Derm Venerol (Stockh) 1994;75:168.
12. Gonzales-Otero F. Cyclosporine in children with severe atopic dermatitis. J Am Acad Dermatolo 1997;36: 1029-30.
13. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000;142:52-8.
14. Harper JI, Berth-Jones J, Camp RD, Dillon MJ, Finlay AY, Holden CA et al. Cyclosporin for atopic dermatitsi in children. Dermatology 2001;203:3-6.
15. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
16. Hanifin JM, Raika G. Diagnostic features of atopic dermatitis. Acta Dermatovenereol 1994;103:589-92.
17. Tanaka Y, Delaporte E, Dubucquoi S, Gounni AS, Porchet E, Capron A et al. Interleukin-5-messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatiti skin. J Invest Dermatol 1994;103:589-92.
18. Chan SC, Brown MA, Willcox TM, Li SH, Stevens SR, Tara D et al. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interaction with IL-4 transcriptional regulatory element. Invest Dermatol 1996;106: 1131-6.
19. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90:323-31.
20. Schneider LC, Baz Z, Zarcone C, Zurakoski D. Long-term therapy with recombinant interferon-gamma (rIFN) for atopic dermatitis. Ann Allergy Asthma Immunol 1998;80:263-8.
21. Bunikowski R, Staab D, Kussebi F, Brautigam M, Weidinger G, Renz H et al. Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 2001;12:216-23.
22. Campbell DE, Kemp AS. Cyclosporin restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol 1997:99:857-9.
23. Farrell AM, Antrobus P, Simpson D, Poweell S, Chapel HM, Ferry BL, A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (T0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Br J Dermatol 2001;144:24-33.